Lung Cancer Screening Based on Type-different Sensor Arrays

In recent years, electronic nose (e-nose) systems have become a focus method for diagnosing pulmonary diseases such as lung cancer. However, principles and patterns of sensor responses in traditional e-nose systems are relatively homogeneous. Less study has been focused on type-different sensor arrays. In this paper, we designed a miniature e-nose system using 14 gas sensors of four types and its subsequent analysis of 52 breath samples. To investigate the performance of this system in identifying and distinguishing lung cancer from other respiratory diseases and healthy controls, five feature extraction algorithms and two classifiers were adopted. Lastly, the influence of type-different sensors on the identification ability of e-nose systems was analyzed. Results indicate that when using the LDA fuzzy 5-NN classification method, the sensitivity, specificity and accuracy of discriminating lung cancer patients from healthy controls with e-nose systems are 91.58%, 91.72% and 91.59%, respectively. Our findings also suggest that type-different sensors could significantly increase the diagnostic accuracy of e-nose systems. These results showed e-nose system proposed in this study was potentially practicable in lung cancer screening with a favorable performance. In addition, it is important for type-different sensors to be considered when developing e-nose systems.

[1]  Q. Jöbsis,et al.  Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review , 2012, Respiratory Research.

[2]  L. Qiu,et al.  A preliminary study , 2018, Medicine.

[3]  S. Papper,et al.  HYPERKALEMIA AND HYPOKALEMIA. , 1964, Disease-a-month : DM.

[4]  H. Haick,et al.  Diagnosing lung cancer in exhaled breath using gold nanoparticles. , 2009, Nature nanotechnology.

[5]  Tarek Mekhail,et al.  Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array , 2007, Thorax.

[6]  H. J. O’neill,et al.  A computerized classification technique for screening for the presence of breath biomarkers in lung cancer. , 1988, Clinical chemistry.

[7]  Julian King,et al.  Stability of selected volatile breath constituents in Tedlar, Kynar and Flexfilm sampling bags. , 2013, The Analyst.

[8]  M. Fiegl,et al.  Noninvasive detection of lung cancer by analysis of exhaled breath , 2009, BMC Cancer.

[9]  O. Fontes [Hepatic coma]. , 1959, Arquivos brasileiros de medicina.

[10]  Haishan Zeng,et al.  A Raman cell based on hollow core photonic crystal fiber for human breath analysis. , 2014, Medical physics.

[11]  N. Ratcliffe,et al.  The importance of methane breath testing: a review , 2013, Journal of breath research.

[12]  J. Skosey,et al.  Breath pentane excretion as a marker of disease activity in rheumatoid arthritis. , 1988, Free radical research communications.

[13]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[14]  G. Sun,et al.  Quantitative breath analysis of volatile organic compounds of lung cancer patients. , 2010, Lung cancer.

[15]  M. Phillips,et al.  Increased pentane and carbon disulfide in the breath of patients with schizophrenia. , 1993, Journal of clinical pathology.

[16]  Ricardo Gutierrez-Osuna,et al.  The how and why of electronic noses , 1998 .

[17]  M. Ledochowski,et al.  Implementation and interpretation of hydrogen breath tests , 2008, Journal of breath research.

[18]  M. Phillips,et al.  Variation in volatile organic compounds in the breath of normal humans. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[19]  H. Haick,et al.  Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors , 2010, British Journal of Cancer.

[20]  B. Buszewski,et al.  Analysis of exhaled breath from smokers, passive smokers and non-smokers by solid-phase microextraction gas chromatography/mass spectrometry. , 2009, Biomedical chromatography : BMC.

[21]  C. Olopade,et al.  Exhaled pentane levels in acute asthma. , 1997, Chest.

[22]  A. Diehl,et al.  Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis , 2001, American Journal of Gastroenterology.

[23]  G. Hanna,et al.  Exhaled breath acetone for therapeutic monitoring in pneumonia using selected ion flow tube mass spectrometry (SIFT-MS) , 2013 .

[24]  Terence H Risby,et al.  Breath biomarkers for detection of human liver diseases: preliminary study , 2002, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[25]  Silvia Conforto,et al.  Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD , 2013, Journal of breath research.

[26]  S. Cunnane,et al.  Epilepsy and the Ketogenic Diet: Assessment of Ketosis in Children Using Breath Acetone , 2002, Pediatric Research.

[27]  Sara Salehi,et al.  Highly sensitive carbon nanotubes–SnO2 nanocomposite sensor for acetone detection in diabetes mellitus breath , 2014 .

[28]  H. Zeng,et al.  A comparison of spectroscopic techniques for human breath analysis , 2012 .

[29]  Raed A Dweik,et al.  The breathprints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[30]  Bogusław Buszewski,et al.  Analysis of exhaled breath for disease detection. , 2014, Annual review of analytical chemistry.

[31]  David Smith,et al.  Breath analysis of ammonia, volatile organic compounds and deuterated water vapor in chronic kidney disease and during dialysis. , 2014, Bioanalysis.

[32]  H. J. O’neill,et al.  Volatile organic compounds in exhaled air from patients with lung cancer. , 1985, Clinical chemistry.

[33]  R. Rosenfeld Patients , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[34]  R. Fall,et al.  Human breath isoprene and its relation to blood cholesterol levels: new measurements and modeling. , 2001, Journal of applied physiology.

[35]  P. Mazzone,et al.  Exhaled breath volatile organic compound biomarkers in lung cancer , 2012, Journal of breath research.

[36]  Eugenio Martinelli,et al.  Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease. , 2016, Current topics in medicinal chemistry.

[37]  I. Hirata,et al.  Breath and blood ammonia in liver cirrhosis. , 2000, Hepato-gastroenterology.

[38]  P. Španěl,et al.  Quantitative analysis of ammonia on the breath of patients in end-stage renal failure. , 1997, Kidney international.

[39]  W. Miekisch,et al.  Breath gas aldehydes as biomarkers of lung cancer , 2009, International journal of cancer.

[40]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[41]  J. Orens,et al.  Patterns and significance of exhaled-breath biomarkers in lung transplant recipients with acute allograft rejection. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[42]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[43]  D. Kavanagh,et al.  Is overexpression of HER-2 a predictor of prognosis in colorectal cancer? , 2009, BMC Cancer.

[44]  R. Dweik,et al.  Isoprene in the Exhaled Breath is a Novel Biomarker for Advanced Fibrosis in Patients with Chronic Liver Disease: A Pilot Study , 2015, Clinical and Translational Gastroenterology.

[45]  L. Bianchi,et al.  Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study , 2005, Respiratory research.

[46]  Paolo Montuschi,et al.  The Electronic Nose in Respiratory Medicine , 2012, Respiration.

[47]  Sorin Draghici,et al.  Machine Learning and Its Applications to Biology , 2007, PLoS Comput. Biol..

[48]  K. Shirato,et al.  Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. , 2000, American journal of respiratory and critical care medicine.

[49]  K. Garey,et al.  Collection and analysis of exhaled breath condensate in humans. , 2001, American journal of respiratory and critical care medicine.

[50]  Chih-Jen Lin,et al.  LIBSVM: A library for support vector machines , 2011, TIST.

[51]  H L Wang,et al.  Relationship between sulcular sulfide level and oral malodor in subjects with periodontal disease. , 2001, Journal of periodontology.

[52]  Olaf Tietje,et al.  Volatile biomarkers of pulmonary tuberculosis in the breath. , 2007, Tuberculosis.

[53]  Tarek Mekhail,et al.  Exhaled Breath Analysis with a Colorimetric Sensor Array for the Identification and Characterization of Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[54]  S. Nair,et al.  Obesity and female gender increase breath ethanol: Potential implications for the pathogenesis of nonalcoholic steatohepatitis , 2000 .